NEW: We've expanded Stock Detail, Screener, and Maps with new data

Stock Detail, Screener:
3, 5, 10-Year Performance
EV/EBITDA, EV/Sales
Dividend Growth (1, 3, 5 Years)
EPS & Sales Growth (3 Years)

Maps:
All from Screener plus:
ROA, ROE, ROIC
Quick & Current Ratios
LT Debt and Debt to Equity Ratios
Gross, Operating, and Net Margins

STIM

Neuronetics Inc

Jul 11 • 04:00PM ET

3.57

Dollar change +0.03
Percentage change 0.85	%

Healthcare • Medical Devices • USA • NASD

Peers: COHR NOVA NVCR GNFT XFOR XERS SENS BLDR CANF

| Held by: VTI IWM VXF IWO PSIL VFMO IWC GSSC RSSL QQQS

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-1.31	Insider Own	44.39%	Shs Outstand	65.82M	Perf Week	5.00%
Market Cap	236.03M	Forward P/E	-	EPS next Y	-0.21	Insider Trans	-1.24%	Shs Float	36.77M	Perf Month	-5.80%
Enterprise Value	301.22M	PEG	-	EPS next Q	-0.08	Inst Own	25.78%	Short Float	11.59%	Perf Quarter	-12.50%
Income	-48.01M	P/S	2.64	EPS this Y	74.08%	Inst Trans	126.91%	Short Ratio	5.37	Perf Half Y	131.82%
Sales	89.45M	P/B	6.63	EPS next Y	42.27%	ROA	-39.06%	Short Interest	4.26M	Perf YTD	121.74%
Book/sh	0.54	P/C	11.01	EPS next 5Y	-	ROE	-152.14%	52W High	5.92 -39.70%	Perf Year	96.15%
Cash/sh	0.32	P/FCF	-	EPS past 3/5Y	-4.00% 2.71%	ROIC	-42.46%	52W Low	0.52 586.54%	Perf 3Y	12.26%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	10.63% 3.63%	Gross Margin	60.81%	Volatility	6.01% 5.81%	Perf 5Y	90.91%
Dividend TTM	-	EV/Sales	3.37	EPS Y/Y TTM	-37.60%	Oper. Margin	-42.70%	ATR (14)	0.21	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	2.28	Sales Y/Y TTM	22.16%	Profit Margin	-53.67%	RSI (14)	48.07	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	2.44	EPS Q/Q	22.80%	SMA20	1.89%	Beta	1.77	Target Price	6.83
Payout	-	Debt/Eq	2.33	Sales Q/Q	83.59%	SMA50	-8.09%	Rel Volume	0.87	Prev Close	3.54
Employees	716	LT Debt/Eq	2.19	Earnings	May 06 BMO	SMA200	26.87%	Avg Volume	794.14K	Price	3.57
IPO	Jun 28, 2018	Option/Short	Yes / Yes	EPS/Sales Surpr.	-69.63% 10.00%	Trades		Volume	688,692	Change	0.85%

Date	Action	Analyst	Rating Change	Price Target Change
Aug-13-24	Downgrade	William Blair	Outperform → Mkt Perform
Oct-13-21	Downgrade	William Blair	Outperform → Mkt Perform
Oct-13-21	Downgrade	BTIG Research	Buy → Neutral
Jan-22-21	Upgrade	William Blair	Mkt Perform → Outperform
Feb-06-20	Initiated	BTIG Research	Buy	$11
Jul-24-18	Initiated	Canaccord Genuity	Buy

Jul-09-25 07:20AM	Neuronetics Showcases NeuroStar TMS Data at Clinical TMS Meeting (Insider Monkey)
Jun-19-25 07:00PM	Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
Jun-10-25 08:31AM	Neuronetics Announces Clinical Presence at the 2025 Clinical TMS Society Annual Meeting and Progress in Greenbrook's Personalized Care Trial Program (GlobeNewswire)
Jun-02-25 04:30PM	Neuronetics Set to Join Russell 2000 and Russell 3000 Indexes (GlobeNewswire)
May-14-25 08:31AM	Neuronetics Launches First Inaugural National TMS Therapy Awareness Day During Mental Health Awareness Month (GlobeNewswire)
03:09AM	Loading…
May-07-25 03:09AM	Neuronetics Inc (STIM) Q1 2025 Earnings Call Highlights: Revenue Surge Amidst Margin Challenges (GuruFocus.com)
May-06-25 08:20AM	Neuronetics (STIM) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
07:20AM	Neuronetics: Q1 Earnings Snapshot (Associated Press Finance)
07:10AM	Neuronetics Reports First Quarter 2025 Financial and Operating Results (GlobeNewswire)
May-05-25 04:30PM	Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
07:40AM	Integra LifeSciences (IART) Q1 Earnings Miss Estimates (Zacks)
Apr-30-25 05:50AM	Why Neuronetics, Inc. (STIM) is Surging in 2025 (Insider Monkey)
Apr-22-25 08:30AM	Neuronetics to Report First Quarter 2025 Financial and Operating Results and Host Conference Call (GlobeNewswire)
Apr-02-25 03:26PM	BrainsWay: Strong Growth Prospects Matter Little To The Market (Seeking Alpha)
Mar-31-25 08:31AM	Evernorth Health Services, a Cigna Company, Expands NeuroStar TMS Coverage for Adolescents Struggling with Depression (GlobeNewswire)
11:45PM	Loading…
Mar-29-25 11:45PM	Neuronetics: Explosive Growth Poised To Soar On FDA Breakthroughs (Seeking Alpha)
Mar-27-25 04:30PM	Neuronetics Reports Updated Fourth Quarter and Full Year 2024 Financial and Operating Results (GlobeNewswire) -5.75%
Mar-18-25 09:55AM	Wall Street Analysts Think Neuronetics (STIM) Could Surge 34.98%: Read This Before Placing a Bet (Zacks)
Mar-05-25 02:06AM	Neuronetics Inc (STIM) Q4 2024 Earnings Call Highlights: Revenue Growth Amidst Rising Expenses ... (GuruFocus.com) +7.11%
Mar-04-25 11:29PM	Q4 2024 Neuronetics Inc Earnings Call (Thomson Reuters StreetEvents) +18.78%
07:36AM	Neuronetics: Q4 Earnings Snapshot (Associated Press Finance)
07:10AM	Neuronetics Reports Fourth Quarter and Full Year 2024 Financial and Operating Results (GlobeNewswire)
Mar-03-25 04:30PM	Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
07:20AM	Neuronetics Inc (STIM) Q4 2024 Earnings Report Preview: What To Look For (GuruFocus.com)
Feb-22-25 05:08PM	Neuronetics, Inc. (STIM): Among the Hot Penny Stocks to Buy Now (Insider Monkey)
Feb-21-25 08:30AM	Neuronetics to Report Fourth Quarter 2024 Financial and Operating Results and Host Conference Call (GlobeNewswire) -13.96%
Feb-07-25 04:30PM	Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire) -13.76% +25.73%
07:54AM	Neuronetics Announces Pricing of $18 Million Underwritten Public Offering of Common Stock (GlobeNewswire)
Feb-06-25 04:23PM	Neuronetics Announces Launch of Underwritten Public Offering of Common Stock (GlobeNewswire) +8.87%
Feb-03-25 07:27PM	Why Neuronetics Inc (STIM) Is Skyrocketing So Far In 2025 (Insider Monkey) +7.81%
08:31AM	Loading…
Jan-29-25 08:31AM	NeuroStar Unveils Two Significant Publications on TMS Therapy for Depression (GlobeNewswire) +6.31%
Jan-13-25 08:00AM	Neuronetics Provides Business Update and Issues 2025 Guidance (GlobeNewswire) +36.84%
Dec-18-24 04:30PM	Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire) +5.38% -5.84%
Dec-16-24 04:30PM	Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire) +19.27%
Dec-10-24 10:00AM	Neuronetics and Greenbrook TMS Announce Closing of Transaction (GlobeNewswire)
Nov-20-24 08:30AM	Neuronetics to Present at the Piper Sandler 36th Annual Healthcare Conference (GlobeNewswire) +6.26%
Nov-13-24 02:10AM	Neuronetics Inc (STIM) Q3 2024 Earnings Call Highlights: Revenue Growth Amid Rising Expenses ... (GuruFocus.com) -11.65%
Nov-12-24 06:45PM	CORRECTION Neuronetics Reports Record Third Quarter 2024 Financial and Operating Results (GlobeNewswire) -37.27%
04:30PM	Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
08:20AM	Neuronetics (STIM) Reports Q3 Loss, Lags Revenue Estimates (Zacks)
07:19AM	Neuronetics: Q3 Earnings Snapshot (Associated Press Finance)
07:10AM	Neuronetics Reports Record Third Quarter 2024 Financial and Operating Results (GlobeNewswire)
Nov-11-24 07:26AM	Neuronetics Inc (STIM) Q3 2024 Earnings Report Preview: What to Expect (GuruFocus.com) -5.98%
Oct-29-24 04:30PM	Neuronetics to Report Third Quarter 2024 Financial and Operating Results and Host Conference Call (GlobeNewswire) +5.94%
Oct-14-24 08:31AM	NeuroStar Oral Presentation at AACAP 2024 Highlights Largest Study Evaluating TMS Efficacy in Adolescents with Depression (GlobeNewswire)
Oct-04-24 08:33AM	Neuronetics and Greenbrook TMS Announce Receipt of Interim Order in Respect of Proposed Arrangement and Provide Details of Shareholder Meetings (PR Newswire) +7.58%
Sep-25-24 08:31AM	Health Care Service Corporation Adds First-Line TMS Coverage for Adolescents (GlobeNewswire) -6.18%
Sep-19-24 08:31AM	Expanded Health Policies Enhance TMS Therapy Access for Adolescents and Adults (GlobeNewswire)
Sep-16-24 08:32AM	NeuroStar Releases Software Upgrades to Elevate Patient Care (GlobeNewswire) +6.70%
Sep-03-24 08:29AM	NeuroStar Honors Suicide Prevention Month With Milestone Achievement and Powerful Stories (GlobeNewswire)
Aug-20-24 08:29AM	NeuroStar Marks Two Years of Transformative Impact with NeuroStar University (GlobeNewswire)
Aug-15-24 05:42AM	Neuronetics inks Greenbrook merger to acquire treatment centers (MedTech Dive) +16.32%
Aug-13-24 12:56PM	Neuronetics' (STIM) Latest Deal to Aid Mental Health Treatments (Zacks)
12:47PM	Neuronetics (STIM) Inks a New Merger Agreement With Greenbrook (Zacks)
09:45AM	Neuronetics (STIM) Q2 Loss Wider Than Expected, Revenues Fall Y/Y (Zacks)
Aug-12-24 08:25AM	Neuronetics (STIM) Reports Q2 Loss, Lags Revenue Estimates (Zacks) -58.15%
07:19AM	Neuronetics: Q2 Earnings Snapshot (Associated Press Finance)
07:15AM	Neuronetics and Greenbrook TMS Announce Definitive Agreement to Merge (GlobeNewswire)
07:10AM	Neuronetics Reports Record Second Quarter 2024 Financial and Operating Results (GlobeNewswire)
Aug-05-24 04:36PM	Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
Aug-01-24 08:29AM	NeuroStar Partners With This Is My Brave to Recognize Teen Mental Health Month (GlobeNewswire)
Jul-31-24 08:30AM	Neuronetics to Present at the Canaccord Genuity 44th Annual Growth Conference (GlobeNewswire)
Jul-30-24 08:30AM	Neuronetics Announces the Closing of up to $90 Million Senior Secured Credit Facility with Perceptive Advisors (GlobeNewswire)
Jul-29-24 08:30AM	Neuronetics to Report Second Quarter 2024 Financial and Operating Results and Host Conference Call (GlobeNewswire)
Jul-22-24 08:31AM	Aetna Policy Update Expands TMS Availability for Adolescents With Depression (GlobeNewswire)
Jul-18-24 10:30AM	3 Neurotech Stocks Bridging Mind and Machine (InvestorPlace) -5.00%
Jul-11-24 12:53PM	TMS in California will have Medicaid coverage for major depressive disorder patients (Medical Device Network)
08:36AM	California Medicaid Adds TMS Access for 14.8 Million Adolescents and Adults (GlobeNewswire)
Jul-10-24 08:32AM	BlueCross BlueShield MI and Cambia Health Solutions Expand TMS Access for Depressed Adolescents (GlobeNewswire)
07:23AM	Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday (InvestorPlace)
Jul-02-24 10:40AM	Neuronetics (STIM) Expands NeuroStar Portfolio With New Launch (Zacks)
Jul-01-24 08:02AM	NeuroStar Launches Better Me Provider Program Nationwide (GlobeNewswire)
Jun-13-24 08:31AM	NeuroStar Showcases Cutting-Edge Research at Clinical TMS Society Annual Meeting (GlobeNewswire)
Jun-07-24 02:38AM	Director Robert Cascella Acquires 50,000 Shares of Neuronetics Inc (STIM) (GuruFocus.com) +10.34%
May-23-24 08:30AM	Neuronetics to Present at the William Blair 44th Annual Growth Stock Conference (GlobeNewswire)
May-15-24 07:32AM	Humana Is First Commercial Payer to Address TMS Therapy Coverage for Adolescents (GlobeNewswire)
May-08-24 09:30AM	Neuronetics, Inc. (NASDAQ:STIM) Q1 2024 Earnings Call Transcript (Insider Monkey)
03:15AM	Neuronetics Inc (STIM) (Q1 2024) Earnings Call Transcript Highlights: Strategic Growth Amidst ... (GuruFocus.com)
May-07-24 11:34PM	Q1 2024 Neuronetics Inc Earnings Call (Thomson Reuters StreetEvents) -30.67%
08:58AM	Neuronetics Inc (STIM) Reports Q1 2024 Earnings: Revenue Surpasses Estimates, Narrowing Losses (GuruFocus.com)
08:40AM	Neuronetics (STIM) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
07:40AM	Neuronetics: Q1 Earnings Snapshot (Associated Press Finance)
07:30AM	Neuronetics Reports Record First Quarter 2024 Financial and Operating Results (GlobeNewswire)
May-03-24 04:30PM	Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire) +8.86%
May-01-24 08:31AM	NeuroStar TMS Advances Treatment for Adolescents During Mental Health Awareness Month (GlobeNewswire) +5.49%
Apr-23-24 04:30PM	Neuronetics to Report First Quarter 2024 Financial and Operating Results and Host Conference Call (GlobeNewswire)
Apr-10-24 08:31AM	New Publication in Brain Stimulation Confirms Full TMS Treatment Course Is Vital (GlobeNewswire)
Apr-01-24 10:52AM	Neuronetics' (STIM) FDA-Cleared NeuroStar to Aid in Depression (Zacks)
Mar-27-24 04:30PM	Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
01:10AM	Neuronetics wins FDA clearance for device to treat adolescents with depression (MedTech Dive)
Mar-25-24 08:30AM	NeuroStar Advanced Therapy Receives FDA Clearance as a First-Line Add-On Treatment for Adolescents with Depression (GlobeNewswire) +11.35%
Mar-08-24 08:06AM	Neuronetics (STIM) Progresses in MRD and TRD With New Deal (Zacks)
Mar-07-24 02:00PM	Neuronetics Inc (STIM) Reports Record Revenues in Q4 and Full Year 2023 (GuruFocus.com)
10:16AM	Neuronetics, Inc. (NASDAQ:STIM) Q4 2023 Earnings Call Transcript (Insider Monkey)
08:22AM	Neuronetics Announces 5-Year Exclusive Partnership with Transformations Care Network (GlobeNewswire)
Mar-05-24 11:39PM	Q4 2023 Neuronetics Inc Earnings Call (Thomson Reuters StreetEvents) +15.41% +24.84%
08:40AM	Neuronetics (STIM) Reports Q4 Loss, Tops Revenue Estimates (Zacks)
07:46AM	Neuronetics: Q4 Earnings Snapshot (Associated Press Finance)
07:30AM	Neuronetics Reports Record Fourth Quarter and Record Full Year 2023 Financial and Operating Results (GlobeNewswire)
Feb-20-24 08:30AM	Neuronetics to Report Fourth Quarter 2023 Financial and Operating Results and Host Conference Call (GlobeNewswire)

Neuronetics, Inc. is a commercial stage medical technology company, which focuses on designing, developing, and marketing products that improve the quality of life for patients who suffer from neurohealth disorders. It operates through United States and International geographical segments. The company was founded by Steven B. Waite, Bruce J. Shook, Norman R. Weldon, and Thomas D. Weldon in 1998 and is headquartered in Malvern, PA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Furlong Stephen	EVP, CFO and Treasurer	May 12 '25	Sale	4.27	193,460	826,074	416,593	May 14 05:05 PM
Furlong Stephen	EVP, CFO and Treasurer	May 13 '25	Sale	4.16	6,540	27,206	410,053	May 14 05:05 PM
Furlong Stephen	Officer	May 13 '25	Proposed Sale	4.16	6,540	27,190		May 13 12:54 PM
Furlong Stephen	Officer	May 12 '25	Proposed Sale	4.27	193,460	826,283		May 12 04:40 PM
Furlong Stephen	EVP, CFO and Treasurer	Mar 04 '25	Sale	4.48	1,867	8,364	610,053	Mar 06 05:00 PM
MACAN WILLIAM ANDREW	EVP, GC, CCO and CS	Mar 04 '25	Sale	4.48	377	1,689	526,805	Mar 06 05:00 PM
MACAN WILLIAM ANDREW	Officer	Mar 04 '25	Proposed Sale	4.48	377	1,688		Mar 04 03:27 PM
Furlong Stephen	Officer	Mar 04 '25	Proposed Sale	4.48	1,867	8,360		Mar 04 03:16 PM
Sullivan Keith J	President and CEO	Feb 19 '25	Sale	4.70	24,440	114,868	1,232,988	Feb 20 05:21 PM
Sullivan Keith J	President and CEO	Feb 18 '25	Sale	4.41	25,934	114,369	1,257,428	Feb 20 05:21 PM
Sullivan Keith J	Officer	Feb 19 '25	Proposed Sale	4.70	24,440	114,760		Feb 19 03:16 PM
MACAN WILLIAM ANDREW	EVP, GC, CCO and CS	Feb 14 '25	Sale	4.11	18,965	77,946	369,682	Feb 18 05:03 PM
Furlong Stephen	EVP, CFO and Treasurer	Feb 14 '25	Sale	4.11	17,307	71,132	454,420	Feb 18 05:02 PM
Sullivan Keith J	Officer	Feb 18 '25	Proposed Sale	4.41	25,934	114,356		Feb 18 03:16 PM
Furlong Stephen	EVP, CFO and Treasurer	Feb 12 '25	Sale	3.83	10,845	41,536	471,727	Feb 14 05:00 PM
MACAN WILLIAM ANDREW	EVP, GC, CCO and CS	Feb 12 '25	Sale	3.83	12,175	46,630	388,647	Feb 14 05:00 PM
Furlong Stephen	Officer	Feb 14 '25	Proposed Sale	4.11	17,307	71,158		Feb 14 03:13 PM
MACAN WILLIAM ANDREW	Officer	Feb 14 '25	Proposed Sale	4.11	18,965	77,975		Feb 14 03:13 PM
MACAN WILLIAM ANDREW	EVP, GC, CCO and CS	Feb 10 '25	Sale	3.28	1,970	6,462	400,822	Feb 12 05:05 PM
Sullivan Keith J	President and CEO	Feb 10 '25	Sale	3.28	40,992	134,454	1,283,362	Feb 12 05:05 PM
Furlong Stephen	EVP, CFO and Treasurer	Feb 10 '25	Sale	3.28	14,836	48,662	482,572	Feb 12 05:05 PM
Furlong Stephen	Officer	Feb 12 '25	Proposed Sale	3.83	10,845	41,554		Feb 12 03:17 PM
MACAN WILLIAM ANDREW	Officer	Feb 12 '25	Proposed Sale	3.83	12,175	46,650		Feb 12 03:08 PM
Sullivan Keith J	Officer	Feb 10 '25	Proposed Sale	3.28	40,992	134,466		Feb 10 03:17 PM
MACAN WILLIAM ANDREW	Officer	Feb 10 '25	Proposed Sale	3.28	1,970	6,462		Feb 10 03:16 PM
Furlong Stephen	Officer	Feb 10 '25	Proposed Sale	3.28	14,836	48,667		Feb 10 03:13 PM
Furlong Stephen	EVP, CFO and Treasurer	Oct 08 '24	Sale	0.82	1,368	1,122	497,408	Oct 10 05:05 PM
MACAN WILLIAM ANDREW	EVP, GC, CCO and CS	Oct 08 '24	Sale	0.82	1,541	1,264	402,792	Oct 10 05:05 PM
Furlong Stephen	Officer	Oct 08 '24	Proposed Sale	0.82	1,368	1,116		Oct 08 03:20 PM
MACAN WILLIAM ANDREW	Officer	Oct 08 '24	Proposed Sale	0.82	1,541	1,257		Oct 08 03:19 PM
CASCELLA ROBERT	Director	Sep 12 '24	Buy	0.75	100,000	75,000	453,098	Sep 13 05:02 PM
MUIR GLENN P	Director	Sep 05 '24	Buy	0.80	25,000	20,000	289,818	Sep 06 05:05 PM
MUIR GLENN P	Director	Aug 28 '24	Buy	0.85	12,776	10,860	252,594	Aug 30 05:15 PM
MUIR GLENN P	Director	Aug 29 '24	Buy	0.85	12,224	10,390	264,818	Aug 30 05:15 PM
MUIR GLENN P	Director	Aug 20 '24	Buy	1.00	25,000	25,000	239,818	Aug 21 05:15 PM
CASCELLA ROBERT	Director	Aug 16 '24	Buy	1.06	35,000	37,100	349,098	Aug 19 05:13 PM
CASCELLA ROBERT	Director	Aug 19 '24	Buy	1.14	4,000	4,560	353,098	Aug 19 05:13 PM
CASCELLA ROBERT	Director	Aug 15 '24	Buy	0.88	35,000	30,800	314,098	Aug 16 05:15 PM
CASCELLA ROBERT	Director	Aug 14 '24	Buy	0.79	35,000	27,650	279,098	Aug 16 05:15 PM
MUIR GLENN P	Director	Aug 14 '24	Buy	0.75	25,171	18,878	214,818	Aug 16 05:15 PM
Sullivan Keith J	President and CEO	Jul 18 '24	Sale	1.90	24,162	45,908	1,324,354	Jul 22 05:23 PM
Sullivan Keith J	President and CEO	Jul 16 '24	Sale	1.91	12,075	23,063	1,360,203	Jul 18 05:21 PM
Sullivan Keith J	President and CEO	Jul 17 '24	Sale	1.97	11,687	23,023	1,348,516	Jul 18 05:21 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

STIM

Neuronetics Inc

Upgrade your FINVIZ experience